Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | BCL11A |
| Upstream (Parents) |
|---|
| (<<) MYB → BCL11A |
| Downstream (Children) |
|---|
| BCL11A → DPEP1 (>>) |
| BCL11A → ASCL2 (>>) |
| BCL11A → LGR5 (>>) |
| BCL11A → TDGF3///TDGF1 (>>) |
| BCL11A → ASAP3 (>>) |
| BCL11A → RPIA (>>) |
| BCL11A → PCOLCE2 (>>) |
| BCL11A → DACH1 (>>) |
| BCL11A → ATP9A (>>) |
| BCL11A → STRN3 (>>) |
| BCL11A → HOXA11 (>>) |
| BCL11A → HLA-DRB6 (>>) |
